Vitro evolution in microfluidic systems
US-9029083-B2 · May 12, 2015 · US
US12534760B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12534760-B2 |
| Application number | US-202519083328-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 18, 2025 |
| Priority date | Dec 22, 2016 |
| Publication date | Jan 27, 2026 |
| Grant date | Jan 27, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure provides compositions, methods, systems, and devices for polynucleotide processing and analyte characterization. Such polynucleotide processing may be useful for a variety of applications, including analyte characterization by polynucleotide sequencing. The compositions, methods, systems, and devices disclosed herein generally describe barcoded oligonucleotides, which can be bound to a bead, such as a gel bead, useful for characterizing one or more analytes including, for example, protein (e.g., cell surface or intracellular proteins), genomic DNA, and RNA (e.g., mRNA or CRISPR guide RNAs). Also described herein, are barcoded labelling agents and oligonucleotide molecules useful for “tagging” analytes for characterization.
Opening claim text (preview).
What is claimed is: 1 . A composition comprising: a partition comprising a plurality of barcode molecules, wherein the plurality of barcode molecules comprises: (a) a first barcode molecule comprising a nucleic acid barcode sequence, wherein the first barcode molecule is hybridized to a first analyte, wherein the first analyte is not messenger ribonucleic acid (mRNA) and is not hybridized to the first barcode molecule via a poly-thymine (poly-T) sequence, wherein the first analyte comprises clustered regularly interspaced short palindromic repeat (CRISPR) ribonucleic acid (crRNA) or single guide ribonucleic acid (sgRNA); and (b) a second barcode molecule comprising the nucleic acid barcode sequence, wherein the second barcode molecule is hybridized to a second analyte, wherein the second analyte is mRNA and is hybridized to the second barcode molecule via a poly-T sequence. 2 . The composition of claim 1 , wherein barcode molecules of the plurality of barcode molecules are attached to a bead. 3 . The composition of claim 2 , wherein the bead is a gel bead. 4 . The composition of claim 2 , wherein the bead comprises polyacrylamide. 5 . The composition of claim 2 , wherein barcode molecules of the plurality of barcode molecules are releasably attached to the bead. 6 . The composition of claim 1 , wherein the partition is a partition among a plurality of partitions. 7 . The composition of claim 6 , wherein the plurality of partitions comprises at least about 1,000; 5,000; 10,000; 50,000; 100,000; 500,000; 1,000,000; 5,000,000; 10,000,000; 50,000,000; 100,000,000, 500,000,000; or 1,000,000,000 partitions. 8 . The composition of claim 6 , wherein the partition is a droplet, and the plurality of partitions is a plurality of droplets. 9 . The composition of claim 6 , wherein the partition is a well, and the plurality of partitions is a plurality of wells. 10 . The composition of claim 1 , wherein the first barcode molecule and the second barcode molecule further comprise a random N-mer sequence. 11 . A composition comprising: a plurality of droplets, wherein a droplet of the plurality of droplets comprises: a gel bead having a plurality of barcode molecules attached thereto, wherein the plurality of barcode molecules comprises: (a) a first barcode molecule comprising a nucleic acid barcode sequence, wherein the first barcode molecule is hybridized to a first analyte, wherein the first analyte is not mRNA and is not hybridized to the first barcode molecule via a poly-T sequence, wherein the first analyte comprises a clustered regularly interspaced short palindromic repeat (CRISPR) ribonucleic acid (crRNA) or a single guide ribonucleic acid (sgRNA); and (b) a second barcode molecule comprising the nucleic acid barcode sequence, wherein the second barcode molecule is hybridized to a second analyte, wherein the second analyte is mRNA and is hybridized to the second barcode molecule via a poly-T sequence, wherein the first barcode molecule and the second barcode molecule further comprise a random N-mer sequence. 12 . A composition comprising: a partition comprising a bead having a plurality of barcode molecules attached thereto, wherein the plurality of barcode molecules comprises: (a) a first population of barcode molecules each hybridized to mRNA via poly-T sequences, wherein barcode molecules of the first population of barcode molecules each comprise a barcode sequence and a random sequence; and (b) a second population of barcode molecules each hybridized to an analyte comprising a clustered regularly interspaced short palindromic repeat (CRISPR) ribonucleic acid (crRNA) or a single guide ribonucleic acid (sgRNA) via a sequence that is not poly-T, wherein barcode molecules of the second population of barcode molecules each comprise a barcode sequence and a random sequence; wherein barcode sequences are constant among the plurality of barcode molecules and random sequences vary among the plurality of barcode molecules. 13 . The composition of claim 12 , wherein the bead is a gel bead. 14 . The composition of claim 12 , wherein the bead comprises polyacrylamide. 15 . The composition of claim 12 , wherein the partition is a partition among a plurality of partitions. 16 . The composition of claim 15 , wherein the plurality of partitions comprises at least about 1,000; 5,000; 10,000; 50,000; 100,000; 500,000; 1,000,000: 5,000,000; 10,000,000; 50,000,000; 100,000,000, 500,000,000; or 1,000,000,000 partitions. 17 . The composition of claim 15 , wherein the partition is a droplet, and the plurality of partitions is a plurality of droplets. 18 . The composition of claim 15 , wherein the partition is a well, and the plurality of partitions is a plurality of wells. 19 . The composition of claim 11 , wherein the bead comprises polyacrylamide. 20 . The composition of claim 11 , wherein the plurality of droplets comprises at least about 1,000; 5,000; 10,000; 50,000; 100,000; 500,000; 1,000,000; 5,000,000; 10,000,000; 50,000,000; 100,000,000; 500,000,000; or 1,000,000,000 droplets.
the label being a nucleic acid · CPC title
Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis · CPC title
incorporating an adaptor · CPC title
involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP] · CPC title
Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.